Do not stop or change any prescribed medication without speaking to the prescribing physician. This page does not advise discontinuation. GLP-1 and GIP/GLP-1 agonists are evidence-based therapies and remain a first-line option for many patients.
Why some patients explore next steps
- Plateau — A1c or weight reduction stalls despite maximal tolerated dose.
- Side effects — persistent nausea, GI symptoms, or muscle loss concerns.
- Cost or access — insurance coverage, supply, or out-of-pocket cost.
- Long-term injection burden — preference for a non-injection pathway.
- Weight regain after discontinuation — published data (STEP, SURMOUNT) show that weight is often regained when these medications are stopped.
What the research suggests about durability
Trials such as STEP-4 (semaglutide) and SURMOUNT-4 (tirzepatide) showed that weight and metabolic benefits diminish when the medication is stopped. This is consistent with how chronic disease treatments usually behave — the benefit lasts as long as the treatment continues. Metabolic surgery is studied as a more durable intervention for selected patients, with effects supported by anatomical and hormonal changes that persist after the procedure.
How metabolic surgery is different
Metabolic surgery — including procedures using the MagDI™ device — is not a substitute for medication in every patient. For some patients, it is studied as a complementary or next-step option after a plateau on GLP-1 therapy. Combining medication with surgery, sequencing treatments, or transitioning between them are all physician-guided decisions.
Common patient questions
Should I stop my GLP-1 before evaluation?
No. Continue all prescribed medications and discuss any change with the prescribing physician. Coordination is part of the evaluation process.
Will surgery let me come off insulin or GLP-1?
Some patients reduce or discontinue diabetes medications after metabolic surgery; others continue them at lower doses. Medication decisions are individualized and made by the treating physician.
Is surgery a cure?
No. Type 2 diabetes does not have a cure. Some patients achieve sustained remission; others see meaningful improvement; some see modest improvement. Outcomes vary.
Education does not replace medical evaluation
Only an individual physician evaluation can determine whether you are a candidate for any procedure. Request an educational evaluation to learn more.
Sources
- Wilding JPH et al. STEP-4: Weight maintenance with semaglutide. JAMA, 2021.
- Aronne LJ et al. SURMOUNT-4: Tirzepatide and weight maintenance. JAMA, 2024.
- ADA Standards of Care in Diabetes — pharmacologic therapy.
- ASMBS / IFSO 2022 Indications for Metabolic and Bariatric Surgery.
Ready for an individualized evaluation?
A physician evaluation is the only way to determine candidacy. Outcomes vary; no result is guaranteed.